Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Sigma-opioid ligands from ADIR

April 26, 1996

U.S. government claims new antipsychotic compositions

April 26, 1996

IRI-695 for anxiety and depression

April 26, 1996

TAD-93 in preclinical studies for anxiety

April 26, 1996

New 5-HT1D antagonists from Pierre Fabre

April 26, 1996

SKB reports 5-HT2B/2C antagonists for CNS indications

April 26, 1996

Adolor aims to advance ADL-2-1294 into clinical trials

April 26, 1996

BMS antimigraine agent poised to enter clinical trials

April 26, 1996

NPC-18688 displays long-lasting antihyperalgesic effects in rodents

April 26, 1996

SKB claims morphinoid derivatives

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...